4.8 News Item

Cancer drugs are closing in on some of the deadliest mutations

Journal

NATURE
Volume 610, Issue 7933, Pages 620-622

Publisher

NATURE PORTFOLIO
DOI: 10.1038/d41586-022-03392-2

Keywords

Cancer; Biotechnology; Drug discovery

Ask authors/readers for more resources

Scientists are aiming to save lives by targeting the mutated KRAS protein with a batch of new compounds, despite it being previously considered 'undruggable'.
The protein KRAS, mutated in many cancers, was deemed 'undruggable'. Now scientists are hoping to save lives with a batch of new compounds that target it. The protein KRAS, mutated in many cancers, was deemed 'undruggable'. Now scientists are hoping to save lives with a batch of new compounds that target it.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available